Patent holdings for IPC class C07J 71/00

Total number of patents in this class: 512

10-year publication summary

44
27
48
41
32
38
35
27
22
17
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
Regeneron Pharmaceuticals, Inc.
4701
20
Nzp UK Limited
29
17
Eli Lilly and Company
4101
16
Reata Pharmaceuticals, Inc.
116
14
Chiesi Farmaceutici S.p.A.
959
11
Sage Therapeutics, LLC
116
11
Beijing Peking University WBL Biotech Co. Ltd
31
9
Neupharma, Inc.
73
9
ALFASIGMA S.p.A.
510
8
AstraZeneca AB
2814
7
Socpra Sciences et Genie S.E.C.
212
7
GENETIC s.p.a.
13
7
Forendo Pharma Ltd.
18
6
Nicox Ophthalmics, Inc.
21
6
Scynexis, Inc.
68
6
Shanghai Institute of Materia Medica, Chinese Academy of Sciences
873
6
Daiichi Sankyo Company, Limited
1890
5
Oncology Research International Limited
5
5
Sage Therapeutics, Inc.
255
5
Duality Biologics (Suzhou) Co., Ltd.
56
5
Other owners 332